Stock listing
NASDAQ:CHRS Coherus Oncology, Inc. Stock
Home listing (NASDAQ) of Coherus Oncology, Inc.
Follow Coherus Oncology, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CHRS
$0.83 USD -0.07 (-7.6%)
Close on Oct 30, 2026
- Day range
- $0.824 – $0.918 USDOct 30, 2026
- Volume
- 2.19M sharesOct 30, 2026
- Market cap
- $128.2M USDAt the close on Oct 30, 2026 · price × 154.5M shares outstanding
- 52-week range
- $0.805 – $2.62 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.66M USDMedian day 1.15M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CHRS · Home | $0.83 USD | -0.068 (-7.6%) | 2,186,100 | $0.90 | $0.918 | $0.824 | $0.898 | Close on Oct 30, 2026 |
| Frankfurt:8C5 | €0.784 EUR | -0.106 (-12.0%) | — | €0.784 | €0.784 | €0.784 | €0.891 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CHRS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.83 | -0.068 | -7.6% | $0.90 | $0.918 | $0.824 | 2,186,100 | |
| $0.898 | -0.262 | -22.6% | $1.15 | $1.15 | $0.805 | 6,132,000 | |
| $1.16 | +0.09 | +8.4% | $1.08 | $1.17 | $1.05 | 1,400,200 | |
| $1.07 | +0.06 | +5.9% | $1.03 | $1.07 | $1.01 | 604,100 | |
| $1.01 | 0.00 | 0.0% | $1.01 | $1.02 | $0.98 | 686,800 | |
| $1.01 | -0.04 | -3.8% | $1.03 | $1.038 | $0.988 | 641,400 | |
| $1.05 | +0.03 | +2.9% | $1.02 | $1.06 | $1.015 | 641,900 | |
| $1.02 | +0.02 | +2.0% | $1.01 | $1.05 | $1.005 | 1,272,500 | |
| $1.00 | +0.041 | +4.3% | $0.96 | $1.03 | $0.955 | 967,700 | |
| $0.959 | -0.031 | -3.1% | $1.00 | $1.015 | $0.94 | 1,726,200 | |
| $0.99 | -0.08 | -7.5% | $1.07 | $1.07 | $0.987 | 938,500 | |
| $1.07 | +0.02 | +1.9% | $1.07 | $1.09 | $1.03 | 1,541,600 | |
| $1.05 | -0.02 | -1.9% | $1.05 | $1.085 | $1.011 | 1,716,300 | |
| $1.07 | +0.04 | +3.9% | $1.06 | $1.08 | $1.00 | 1,342,100 | |
| $1.03 | -0.04 | -3.7% | $1.06 | $1.066 | $1.03 | 1,036,300 | |
| $1.07 | 0.00 | 0.0% | $1.06 | $1.12 | $1.05 | 1,697,100 | |
| $1.07 | +0.06 | +5.9% | $1.01 | $1.07 | $0.974 | 2,135,100 | |
| $1.01 | -0.02 | -1.9% | $1.02 | $1.08 | $1.01 | 1,233,300 | |
| $1.03 | -0.09 | -8.0% | $1.13 | $1.13 | $1.01 | 2,965,300 | |
| $1.12 | -0.04 | -3.4% | $1.16 | $1.16 | $1.08 | 2,008,500 | |
| $1.16 | 0.00 | 0.0% | $1.19 | $1.19 | $1.145 | 1,183,200 | |
| $1.16 | -0.05 | -4.1% | $1.20 | $1.21 | $1.145 | 709,200 | |
| $1.21 | +0.03 | +2.5% | $1.18 | $1.23 | $1.155 | 1,579,800 | |
| $1.18 | +0.04 | +3.5% | $1.15 | $1.20 | $1.12 | 1,346,800 | |
| $1.14 | +0.01 | +0.9% | $1.13 | $1.15 | $1.10 | 1,143,300 | |
| $1.13 | -0.04 | -3.4% | $1.17 | $1.185 | $1.13 | 1,221,400 | |
| $1.17 | -0.09 | -7.1% | $1.25 | $1.265 | $1.17 | 1,561,600 | |
| $1.26 | -0.04 | -3.1% | $1.30 | $1.31 | $1.21 | 1,615,700 | |
| $1.30 | -0.07 | -5.1% | $1.39 | $1.39 | $1.22 | 4,535,100 | |
| $1.37 | +0.02 | +1.5% | $1.35 | $1.43 | $1.30 | 1,489,500 | |
| $1.35 | +0.12 | +9.8% | $1.23 | $1.35 | $1.225 | 3,121,100 | |
| $1.23 | +0.01 | +0.8% | $1.26 | $1.27 | $1.18 | 1,885,500 | |
| $1.22 | -0.11 | -8.3% | $1.34 | $1.35 | $1.21 | 1,289,600 | |
| $1.33 | -0.10 | -7.0% | $1.38 | $1.39 | $1.32 | 762,000 | |
| $1.43 | +0.10 | +7.5% | $1.34 | $1.43 | $1.34 | 1,274,900 | |
| $1.33 | -0.01 | -0.7% | $1.378 | $1.38 | $1.325 | 529,200 | |
| $1.34 | +0.02 | +1.5% | $1.33 | $1.36 | $1.30 | 1,019,100 | |
| $1.32 | -0.05 | -3.6% | $1.34 | $1.375 | $1.31 | 840,600 | |
| $1.37 | -0.05 | -3.5% | $1.40 | $1.43 | $1.36 | 549,200 | |
| $1.42 | +0.05 | +3.6% | $1.38 | $1.435 | $1.38 | 304,100 | |
| $1.37 | -0.05 | -3.5% | $1.42 | $1.43 | $1.36 | 437,200 | |
| $1.42 | +0.05 | +3.6% | $1.37 | $1.435 | $1.355 | 621,400 | |
| $1.37 | +0.02 | +1.5% | $1.36 | $1.40 | $1.35 | 695,100 | |
| $1.35 | -0.06 | -4.3% | $1.39 | $1.41 | $1.30 | 1,127,700 | |
| $1.41 | -0.05 | -3.4% | $1.45 | $1.48 | $1.40 | 604,800 | |
| $1.46 | +0.01 | +0.7% | $1.43 | $1.48 | $1.41 | 788,300 | |
| $1.45 | +0.08 | +5.8% | $1.37 | $1.455 | $1.34 | 896,500 | |
| $1.37 | +0.01 | +0.7% | $1.36 | $1.41 | $1.31 | 1,297,214 | |
| $1.36 | -0.06 | -4.2% | $1.43 | $1.43 | $1.35 | 1,046,359 | |
| $1.42 | +0.10 | +7.6% | $1.32 | $1.44 | $1.315 | 1,565,300 | |
| $1.32 | -0.01 | -0.8% | $1.31 | $1.34 | $1.27 | 740,200 | |
| $1.33 | -0.01 | -0.7% | $1.379 | $1.405 | $1.295 | 3,038,100 | |
| $1.34 | +0.19 | +16.5% | $1.26 | $1.36 | $1.22 | 3,477,700 | |
| $1.15 | -0.05 | -4.2% | $1.20 | $1.20 | $1.13 | 1,264,600 | |
| $1.20 | +0.06 | +5.3% | $1.16 | $1.205 | $1.14 | 648,300 | |
| $1.14 | -0.03 | -2.6% | $1.18 | $1.195 | $1.13 | 1,060,000 | |
| $1.17 | -0.04 | -3.3% | $1.21 | $1.246 | $1.17 | 1,155,500 | |
| $1.21 | -0.03 | -2.4% | $1.25 | $1.26 | $1.18 | 968,300 | |
| $1.24 | -0.03 | -2.4% | $1.33 | $1.34 | $1.23 | 978,100 | |
| $1.27 | +0.005 | +0.4% | $1.27 | $1.40 | $1.24 | 1,600,200 | |
| $1.265 | -0.185 | -12.8% | $1.385 | $1.455 | $1.131 | 3,721,800 | |
| $1.45 | -0.03 | -2.0% | $1.48 | $1.525 | $1.435 | 999,300 | |
| $1.48 | +0.04 | +2.8% | $1.43 | $1.50 | $1.43 | 617,700 | |
| $1.44 | +0.03 | +2.1% | $1.42 | $1.459 | $1.414 | 477,300 | |
| $1.41 | -0.06 | -4.1% | $1.48 | $1.48 | $1.40 | 436,900 | |
| $1.47 | +0.06 | +4.3% | $1.42 | $1.485 | $1.415 | 508,900 |
- Ticker
- NASDAQ:CHRS
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
Latest earnings call · Aug 5, 2026
Coherus Oncology (NASDAQ:CHRS) Q2 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 25 slides
Calls
Upcoming
Coherus Oncology (NASDAQ:CHRS) Q3 2026 Earnings Call
Mon, Nov 09, 2026 · 5:00 PM ET
Register
Replays
Coherus Oncology (NASDAQ:CHRS) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 5:00 PM ET
Watch TranscriptCoherus Oncology (NASDAQ:CHRS) Q1 2026 Earnings Call
Mon, May 11, 2026 · 5:00 PM ET
Watch TranscriptCoherus Oncology (NASDAQ:CHRS) Q4 2025 Earnings Call
Mon, Mar 09, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
Oct 28, 2026
Closed $0.898 (-22.6%) on Oct 29, 2026
Coherus to Participate in Upcoming Investor Conferences
Oct 27, 2026
Closed $1.07 (+5.9%) on Oct 27, 2026
Coherus Oncology to Report Third Quarter 2026 Financial Results on November 9, 2026
Oct 26, 2026
Closed $1.01 (0.0%) on Oct 26, 2026
Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026
Oct 14, 2026
Closed $1.07 (+1.9%) on Oct 15, 2026
Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets
Sep 23, 2026
Closed $1.26 (-3.1%) on Sep 23, 2026
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
Aug 17, 2026
Closed $1.34 (+16.5%) on Aug 18, 2026
Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update
Aug 5, 2026
Closed $1.27 (-12.8%) on Aug 6, 2026
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
Jul 22, 2026
Closed $1.43 (-2.7%) on Jul 22, 2026
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
Jun 23, 2026
Closed $1.46 (-1.4%) on Jun 23, 2026
Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update
May 11, 2026
Closed $1.95 (+11.4%) on May 11, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 25 slides · September 2026
Q4 2025 Earnings Presentation
Earnings · 30 slides · Mar 9, 2026
Coherus BioSciences — 43rd Annual J.P. Morgan Healthcare Conference January 2025
Conference · 42 slides · Jan 14, 2025
Coherus BioSciences — Bank of America Merrill Lynch Health Care Conference 2016
Conference · 31 slides · May 11, 2016
Coherus Oncology, Inc. on 6ix
- News releases
- 24 in the last 12 months · 160 in all · newest Oct 28, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest Aug 5, 2026
- Decks
- 4 decks · latest September 2026
Where Coherus Oncology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CHRS · Home listing · This page | NASDAQ | United States | USD |
| Tradegate:8C5 | Tradegate | Germany | EUR |
| gettex:8C5 | gettex | Germany | EUR |
| Lang & Schwarz:A12ETZ | Lang & Schwarz | Germany | EUR |
| LS Exchange:A12ETZ | LS Exchange | Germany | EUR |
| BOATS:CHRS | BOATS | United States | USD |
| BX Swiss:8C5 | BX Swiss | Switzerland | CHF |
| Dusseldorf:8C5 | Dusseldorf | Germany | EUR |
| Frankfurt:8C5 | Frankfurt | Germany | EUR |
| Munich:8C5 | Munich | Germany | EUR |
| Stuttgart:8C5 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Coherus Oncology, Inc.